Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Global X NASDAQ 100 Covered Call ETF trades at $18.63 (market cap $8.54B). The key difference: Global X NASDAQ 100 Covered Call ETF is the larger of the two by market cap, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Global X NASDAQ 100 Covered Call ETF for 51 Days on average.
| ORKA | QYLD | |
|---|---|---|
Market Cap | $5.08B | $8.54B |
Volume | 685,276 | 2,727,578 |
Sector | Health | Income / Options Overlay |
52-Week High | $113.08 | $18.69 |
52-Week Low | $26.19 | $16.70 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $4.21B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QYLD trades at $18.69, showing minimal daily movement with a 0.05% gain. The ETF maintains its covered call strategy on the Nasdaq 100, generating consistent monthly dividends of $0.18 per share. Technical indicators show mixed signals with moving averages bullish but oscillators bearish, while RSI levels above 75 suggest overbought conditions. Recent news highlights concerns about principal erosion despite the attractive yield.
The outlook remains cautious as QYLD's high yield comes with capped upside potential during market rallies. While providing reliable monthly income, the strategy sacrifices long-term capital appreciation. Key risks include declining option premiums and tax treatment uncertainties that could impact total returns for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
